Evidence map›Paper›PMID 31903883›Full record

ReviewCurrent neuropharmacology2020

Neuroprotective Polyphenols: A Modulatory Action on Neurotransmitter Pathways.

Elzbieta Rebas, Jowita Rzajew, Tomasz Radzik, Ludmila Zylinska

Open access · greenAbstract readReview
In one paragraph

Review in Current neuropharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 87 citations in OpenAlex.

  1. Trial
  2. Review
  3. Optimization and Metabolomic Profiling ofInternational journal of molecular sciences · 2026
    Article
  4. International journal of molecular sciences · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Therapeutic potential ofIn silico pharmacology · 2026
    Article
  15. Multi-Target Neuroprotective Effects of Flavonoid-RichInternational journal of molecular sciences · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elzbieta RebasDepartment of Molecular Neurochemistry, Faculty of Health Sciences, Medical University of Lodz, Lodz, Poland.
Jowita RzajewDepartment of Molecular Neurochemistry, Faculty of Health Sciences, Medical University of Lodz, Lodz, Poland.
Tomasz RadzikDepartment of Molecular Neurochemistry, Faculty of Health Sciences, Medical University of Lodz, Lodz, Poland.
Ludmila ZylinskaDepartment of Molecular Neurochemistry, Faculty of Health Sciences, Medical University of Lodz, Lodz, Poland.
Medical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBalance in neurotransmission is essential for the proper functioning of the nervous system and even a small, but prolonged disturbance, can induce the negative feedback mechanisms leading to various neuropathologies. Neurodegenerative and mood disorders such as Alzheimer's, Parkinson's or affective disorders are increasing medical and social problems. Among the wide spectrum of potentially destructive events, oxidative stress and disrupted metabolism of some neurotransmitters such as acetylcholine, GABA, glutamate, serotonin or dopamine appear to play a decisive role. Biologically active plant polyphenols have been shown to exert a positive impact on the function of the central nervous system by modulation of metabolism and the action of some neurotransmitters.

methodsBased on published research, the pharmacological activities of some naturally occurring polyphenols have been reviewed, with a focus on their potential therapeutic importance in the regulation of neurotransmitter systems.

resultsPhytochemicals can be classified into several groups and most of them possess anticancer, antioxidative, anti-inflammatory and neuroprotective properties. They can also modulate the metabolism or action of some neurotransmitters and/or their receptors. Based on these properties, phytochemicals have been used in traditional medicine for ages, although it was focused mainly on treating symptoms. However, growing evidence indicates that polyphenols may also prevent or slow neurological diseases.

conclusionPhytochemicals seem to be less toxic than synthetic drugs and they can be a safer alternative for currently used preparations, which exert adverse side effects. The neuroprotective actions of some plant polyphenols in the regulation of neurotransmitters metabolism, functioning of neurotransmitters receptors and antioxidative defense have potential therapeutic applications in various neurodegenerative disorders.

Indexed as

AnimalsBrainHumansNervous System DiseasesNeuronsNeuroprotective AgentsPolyphenolsSynaptic TransmissionNeuroprotective AgentsPolyphenolscentral nervous systemneuropathologyneuroprotectionneurotransmitter receptorsneurotransmitters.Polyphenols

Identifiers

PMID31903883
PMCPMC7457434
OpenAlexW2999145612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.